Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Janardan Pandey and Aryan Namboodiri.
Janardan Pandey
Connection Strength
5.273
Aryan Namboodiri
  1. Immunoglobulin GM and Fc?RIIIa genotypes influence cytotoxicity of neuroblastoma cells. J Neuroimmunol. 2014 May 15; 270(1-2):95-7.
    View in: PubMed
    Score: 0.474
  2. Genetic variants of IgG1 antibodies and Fc?RIIIa receptors influence the magnitude of antibody-dependent cell-mediated cytotoxicity against prostate cancer cells. Oncoimmunology. 2014 Jan 01; 3(1):e27317.
    View in: PubMed
    Score: 0.467
  3. Humoral immunity to cytomegalovirus and chronic graft-versus-host disease. Viral Immunol. 2012 Aug; 25(4):338-40.
    View in: PubMed
    Score: 0.422
  4. The human cytomegalovirus TRL11/IRL11-encoded Fc?R binds differentially to allelic variants of immunoglobulin G1. Arch Virol. 2011 May; 156(5):907-10.
    View in: PubMed
    Score: 0.383
  5. Hepatitis C virus core protein discriminates between the two IgG2 allotypes. Viral Immunol. 2008 Jun; 21(2):273-6.
    View in: PubMed
    Score: 0.317
  6. Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes. Mol Immunol. 2007 Jul; 44(15):3805-8.
    View in: PubMed
    Score: 0.295
  7. Immunoglobulin ? chain allotypes and humoral immunity to HSV1 in Parkinson's disease. J Neuroimmunol. 2022 10 15; 371:577948.
    View in: PubMed
    Score: 0.212
  8. Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. J Cyst Fibros. 2021 11; 20(6):1080-1084.
    View in: PubMed
    Score: 0.197
  9. Inhibitory Fc? Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease. J Alzheimers Dis. 2021; 84(3):965-968.
    View in: PubMed
    Score: 0.190
  10. Association of immunoglobulin GM allotypes with longevity in long-living individuals from Southern Italy. Immun Ageing. 2018; 15:26.
    View in: PubMed
    Score: 0.164
  11. IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls. Hum Immunol. 2018 Aug; 79(8):632-637.
    View in: PubMed
    Score: 0.159
  12. Endogenous antibody responses to mucin 1 in a large multiethnic cohort of patients with breast cancer and healthy controls: Role of immunoglobulin and Fc? receptor genes. Immunobiology. 2018 02; 223(2):178-182.
    View in: PubMed
    Score: 0.152
  13. Immunoglobulin genotypes and cognitive functions in schizophrenia. Immunogenetics. 2018 01; 70(1):67-72.
    View in: PubMed
    Score: 0.151
  14. Genetic markers of immunoglobulin G and immunity to cytomegalovirus in patients with breast cancer. Cell Immunol. 2017 02; 312:67-70.
    View in: PubMed
    Score: 0.142
  15. Immunoglobulin G genotypes and the risk of schizophrenia. Hum Genet. 2016 10; 135(10):1175-9.
    View in: PubMed
    Score: 0.139
  16. Humoral Immunity to Cytomegalovirus Glycoprotein B in Patients With Breast Cancer and Matched Controls: Contribution of Immunoglobulin ?, ?, and Fc? Receptor Genes. J Infect Dis. 2016 Feb 15; 213(4):611-7.
    View in: PubMed
    Score: 0.132
  17. The decoy Fc? receptor encoded by the cytomegalovirus UL119-UL118 gene has differential affinity to IgG proteins expressing different GM allotypes. Hum Immunol. 2015 Aug; 76(8):591-4.
    View in: PubMed
    Score: 0.131
  18. Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma. Neuro Oncol. 2015 May; 17(5):678-84.
    View in: PubMed
    Score: 0.123
  19. Immunoglobulin genes influence the magnitude of humoral immunity to cytomegalovirus glycoprotein B. J Infect Dis. 2014 Dec 01; 210(11):1823-6.
    View in: PubMed
    Score: 0.121
  20. Suggestive evidence that Fc variants of IgG2 and Fc?RIIa loci interact to contribute to the risk of prostate cancer. Hum Immunol. 2013 Dec; 74(12):1656-8.
    View in: PubMed
    Score: 0.114
  21. IGKC and Fc?R genotypes and humoral immunity to HER2 in breast cancer. Immunobiology. 2014 Feb; 219(2):113-7.
    View in: PubMed
    Score: 0.114
  22. IgG and Fc?R genotypes and humoral immunity to mucin 1 in prostate cancer. Hum Immunol. 2013 Aug; 74(8):1030-3.
    View in: PubMed
    Score: 0.111
  23. Immunoglobulin genes and the acquisition of HIV infection in a randomized trial of recombinant adenovirus HIV vaccine. Virology. 2013 Jun 20; 441(1):70-4.
    View in: PubMed
    Score: 0.111
  24. A genetic variant of Fc?RIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer. Immunogenetics. 2013 Feb; 65(2):91-6.
    View in: PubMed
    Score: 0.108
  25. Genetic regulation of antibody responses to human epidermal growth factor receptor 2 in breast cancer. Hum Immunol. 2010 Nov; 71(11):1124-7.
    View in: PubMed
    Score: 0.093
  26. Genetic markers of IgG influence the outcome of infection with hepatitis C virus. J Infect Dis. 2008 Nov 01; 198(9):1334-6.
    View in: PubMed
    Score: 0.082
  27. IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis. Autoimmunity. 2004 May; 37(3):241-4.
    View in: PubMed
    Score: 0.060
  28. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. Lancet HIV. 2019 10; 6(10):e667-e679.
    View in: PubMed
    Score: 0.043
  29. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 01; 15(1):e1002493.
    View in: PubMed
    Score: 0.039
  30. Association between immunoglobulin GM and KM genotypes and placental malaria in HIV-1 negative and positive women in western Kenya. PLoS One. 2013; 8(1):e53948.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.